The Endocrine Dilemma: Untangling Canine Hormonal Imbalances

When a middle-aged or senior dog begins developing progressive alopecia (hair thinning), darkening skin pigmentation (hyperpigmentation), and generalized lethargy, veterinarians face a frequent diagnostic challenge: determining whether the underlying dysfunction originates in the thyroid gland (Hypothyroidism) or the adrenal cortex (Cushing’s Disease).

Because both conditions represent common endocrine disorders in dogs between 6 and 12 years of age, symptoms often overlap on surface physical examination. However, misdiagnosing one for the other or treating without definitive laboratory confirmation can trigger life-threatening iatrogenic complications—such as precipitating an acute Addisonian crisis with excess trilostane or inducing thyrotoxicosis with inappropriate levothyroxine dosing.

Clinical Symptoms Comparison: Slow Metabolism vs Cortisol Excess

To distinguish between these two endocrine conditions in a clinical triage setting:

Laboratory Diagnostics: The Definitive Blood Testing Protocol

Because non-thyroidal systemic illness (“euthyroid sick syndrome”) can suppress circulating thyroid hormones in dogs with Cushing’s disease, clinicians must adhere to a strict diagnostic order of operations:

1. Testing for Hypothyroidism

• Total T4 (TT4): A valuable screening tool. If TT4 is well within the upper reference range, hypothyroidism is highly unlikely. However, low TT4 alone is not diagnostic because concurrent illnesses (including Cushing’s, diabetes, or arthritis) falsely depress TT4.
• Free T4 by Equilibrium Dialysis (fT4-ED): The clinical gold standard. Free T4 measures unbound, biologically active thyroxine that is unaffected by non-thyroidal illness.
• Canine Thyroid Stimulating Hormone (cTSH): Elevated cTSH combined with low fT4 confirms primary hypothyroidism (as the pituitary pumps excess TSH trying to stimulate failing thyroid follicles).

2. Testing for Cushing’s Disease

• Alkaline Phosphatase (ALP) Isoenzyme: Over 90% of dogs with Cushing’s exhibit dramatic elevations in liver ALP (often 1,000 to 4,000+ U/L) due to cortisol-induced hepatic glycogen storage.
• Low-Dose Dexamethasone Suppression Test (LDDST): The screening test of choice. Baseline cortisol is drawn, 0.015 mg/kg dexamethasone is injected intravenously, and cortisol is measured at 4 and 8 hours. In a healthy dog, dexamethasone suppresses cortisol below 1.4 ug/dL at 8 hours. Failure to suppress confirms Cushing’s disease.
• ACTH Stimulation Test: Evaluates adrenocortical reserve. While slightly less sensitive than LDDST for pituitary tumors, it is mandatory for diagnosing iatrogenic Cushing’s and monitoring trilostane therapy.

Pharmacological Interventions: Levothyroxine vs Trilostane

Medical management targets completely different endocrine pathways:

• Hypothyroidism Management: Treated with synthetic levothyroxine sodium (e.g. Thyro-Tabs) administered at 0.02 mg/kg twice daily on an empty stomach. Because thyroid hormones regulate metabolic rate, energy levels rebound within 1 to 2 weeks, while skin and coat re-growth takes 6 to 12 weeks. Post-pill peak T4 blood levels are checked 4 to 6 hours after dosing every 6 months.
• Cushing’s Disease Management: Treated with trilostane (Vetoryl), an enzyme inhibitor that blocks 3-beta-hydroxysteroid dehydrogenase, halting cortisol synthesis in the adrenal cortex. Dosing begins conservatively at 1 to 2 mg/kg once daily with food. Frequent ACTH stimulation testing is mandatory during the first 90 days to ensure the adrenal glands are not overly suppressed into hypoadrenocorticism.

Breed Predispositions & Autoimmune Thyroiditis Pathology

Understanding which canine breeds carry genetic susceptibility to endocrine collapse allows guardians to initiate baseline laboratory screening early in life:

• Hypothyroidism Breeds: Highly prevalent in Golden Retrievers, Doberman Pinschers, Labrador Retrievers, Cocker Spaniels, and Irish Setters. In over 50% of cases, the underlying cause is Lymphocytic Thyroiditis—an autoimmune condition where circulating autoantibodies (Thyroglobulin Autoantibodies / TgAA) infiltrate and systematically destroy thyroid follicles over 2 to 4 years before clinical signs manifest.
• Cushing’s Disease Breeds: Pituitary-dependent hyperadrenocorticism (PDH) disproportionately strikes small and medium breeds under 20 kg, including Miniature Poodles, Dachshunds, Boston Terriers, Yorkshire Terriers, and Boxers. Adrenal tumors (ADH), conversely, are equally distributed across large and small dogs.

Concurrent Secondary Complications: Hypertension, Proteinuria & Infections

Endocrine diseases do not exist in isolation; chronic hormonal dysregulation triggers severe multi-system organ damage:

In Cushing’s disease, chronic excess glucocorticoids act as potent systemic immunosuppressants. Up to 50% of dogs with Cushing’s develop occult urinary tract infections (UTIs) that exhibit zero clinical symptoms (no painful straining or foul odor) because cortisol suppresses inflammatory white blood cell migration into the bladder. Routine sterile cystocentesis urinalysis and urine culture are mandatory every 6 months. Furthermore, cortisol drives renal sodium retention, causing systemic hypertension in over 70% of canine patients, predisposing them to acute retinal detachment and hypertensive stroke if unmanaged.

Therapeutic Monitoring & Peak Post-Pill Hormone Curves

Once medical management begins, ongoing therapeutic monitoring is vital to ensure optimal clinical outcomes:

For hypothyroid dogs receiving levothyroxine, peak serum T4 levels must be evaluated exactly 4 to 6 hours post-pill after 4 to 8 weeks of consistent therapy. The target post-pill T4 should reside comfortably in the high-normal range (3.0 to 5.0 ug/dL). In Cushing’s patients receiving trilostane, the post-pill ACTH stimulation test is traditionally conducted 4 to 6 hours after morning administration, targeting post-ACTH cortisol levels between 1.5 and 5.0 ug/dL to prevent both relapse and lethal hypoadrenocorticism.

FAQ: Dog Hypothyroidism vs Cushing’s Disease